The role of prolactin/vasoinhibins in cardiovascular diseases

被引：3
作者：
Zhao, Hui [1 ,2 ,3 ]
Gong, Sugang [3 ]
Shi, Yongcong [4 ]
Luo, Cijun [3 ]
Qiu, Hongling [3 ]
He, Jing [3 ]
Sun, Yuanyuan [3 ]
Huang, Yuxia [3 ]
Wang, Shang [3 ]
Miao, Yuqing [1 ,2 ]
Wu, Wenhui [3 ]
机构：
[1] Univ Shanghai Sci & Technol, Sch Mat & Chem, Shanghai 200093, Peoples R China
[2] Univ Shanghai Sci & Technol, Inst Bismuth & Rhenium, Shanghai 200093, Peoples R China
[3] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Cardiopulm Circulat, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[4] Dongchuan Dist Peoples Hosp, Resp Med, Kunming, Yunnan, Peoples R China
来源：
ANIMAL MODELS AND EXPERIMENTAL MEDICINE | 2023年 / 6卷 / 02期
基金：
上海市自然科学基金; 中国国家自然科学基金;
关键词：
cardiovascular diseases; endothelial cells; prolactin; vasoinhibins; SERUM PROLACTIN CONCENTRATIONS; ENDOTHELIAL-CELLS; PERIPARTUM CARDIOMYOPATHY; PRECLINICAL ATHEROSCLEROSIS; CATHEPSIN-D; 16K PRL; RISK; SECRETION; DYSFUNCTION; EXPRESSION;
D O I：
10.1002/ame2.12264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Prolactin (PRL) is a polypeptide hormone that is mainly synthesized and secreted by the lactotroph cells of the pituitary. There are two main isoforms of PRL: 23-kDa PRL (named full-length PRL) and vasoinhibins (including 5.6-18 kDa fragments). Both act as circulating hormones and cytokines to stimulate or inhibit vascular formation at different stages and neovascularization, including endothelial cell proliferation and migration, protease production, and apoptosis. However, their effects on vascular function and cardiovascular diseases are different or even contrary. In addition to the structure, secretion regulation, and signal transduction of PRL/vasoinhibins, this review focuses on the pathological mechanism and clinical significance of PRL/vasoinhibins in cardiovascular diseases.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [31] The potential role of miRNAs in the pathogenesis of cardiovascular diseases - A focus on signaling pathways interplay
    Khidr, Emad Gamil
    Abulsoud, Ahmed I.
    Doghish, Ayman A.
    El-Mahdy, Hesham A.
    Ismail, Ahmed
    Elballal, Mohammed S.
    Sarhan, Omnia M.
    Mageed, Sherif S. Abdel
    Elsakka, Elsayed G. E.
    Elkhawaga, Samy Y.
    El-Husseiny, Ahmed A.
    Abdelmaksoud, Nourhan M.
    El-Demerdash, Aya A.
    Shahin, Reem K.
    Midan, Heba M.
    Elrebehy, Mahmoud A.
    Mohammed, Osama A.
    Abulsoud, Logyna A.
    Doghish, Ahmed S.
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [32] Increasing evidence of pathogenic role of the Mediator (MED) complex in the development of cardiovascular diseases
    Napoli, C.
    Schiano, C.
    Soricelli, A.
    BIOCHIMIE, 2019, 165 : 1 - 8
  • [33] Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)
    Zhang, Kaijie
    Li, Miaomiao
    Yin, Li
    Fu, Guosheng
    Liu, Zhenjie
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 45 (05) : 1275 - 1293
  • [34] Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis
    Mir, Rashid
    Elfaki, Imadeldin
    Khullar, Naina
    Waza, Ajaz Ahmad
    Jha, Chandan
    Mir, Mohammad Muzaffar
    Nisa, Shamsu
    Mohammad, Babar
    Mir, Tahir Ahmad
    Maqbool, Mohsin
    Barnawi, Jameel
    Albalawi, Salem Owaid
    Abu-Duhier, Faisel M.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (02) : 1 - 17
  • [35] Role of lipins in cardiovascular diseases
    Ding, Zerui
    Song, Hongyu
    Wang, Fang
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [36] Role of Magnesium in Cardiovascular Diseases
    Kolte, Dhaval
    Vijayaraghavan, Krishnaswami
    Khera, Sahil
    Sica, Domenic A.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2014, 22 (04) : 182 - 192
  • [37] Role of DHEA in cardiovascular diseases
    Savineau, Jean-Pierre
    Marthan, Roger
    de la Roque, Eric Dumas
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (06) : 718 - 726
  • [38] Role of oxylipins in cardiovascular diseases
    Nayeem, Mohammed A.
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (07) : 1142 - 1154
  • [39] Role of lipins in cardiovascular diseases
    Zerui Ding
    Hongyu Song
    Fang Wang
    Lipids in Health and Disease, 22
  • [40] Role of pyroptosis in cardiovascular diseases
    Jia, Chang
    Chen, Huanwen
    Zhang, Jian
    Zhou, Kailiang
    Zhuge, Yingzhi
    Niu, Chao
    Qiu, Jianxin
    Rong, Xing
    Shi, Zhewei
    Xiao, Jian
    Shi, Yong
    Chu, Maoping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 311 - 318
12345